foxo4-dri senolytic 2023 2024 study peptide mouse Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI FOXO4-DRI regulates endothelial cell senescence
FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications foxo4 dri senolytic peptide human trial 2024 FOXO4 DRI UK Senolytic Peptide Research Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies
Pay in 4 interest-free payments of $6.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





